Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Complex treatment of colorectal liver metastases Consensus Conference, Budapest, 5th April 2019].
Magyar Hepato-Pancreatico-Biliaris (HPB) Kutatócsoport, Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest, Üllői út 78., 1082 Hungary; András C, Bartek P, Battyáni I, Bezsilla J, Bodoky G, Bogner B, Bursics A, Csőszi T, Damjanovich L, Dank M, Dankovics Z, Deák PÁ, Dede K, Doros A, Dudás I, Györke T, Hahn O, Hartmann E, Hitre E, Horváth Z, Imre M, Kalmár Nagy K, Káposztás Z, Kóbori L, Kupcsulik P, Landherr L, Lóderer Z, Mangel L, Máthé Z, Mersich T, Mezei K, Mohos E, Oláh A, Pajor P, Palkó A, Pápai Z, Papp A, Patyánik M, Petri A, Révész J, Ruzsa Á, Schlachter K, Sikorszki L, Sipőcz I, Székely E, Szijártó A, Torday L, Tóth LB, Dósa E, Harsányi L, István G, Landherr L, Lázár G, Lövey J, Schaff Z, Szűcs Á, Vereczkei A. Magyar Hepato-Pancreatico-Biliaris (HPB) Kutatócsoport, Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest, Üllői út 78., 1082 Hungary, et al. Among authors: dank m. Orv Hetil. 2019 Sep;160(Suppl 2):2-20. doi: 10.1556/650.2019.31580. Orv Hetil. 2019. PMID: 31565959 Hungarian. No abstract available.
[Potential role of estrogens in colorectal tumour development].
Leiszter K, Galamb O, Kalmár A, Zsigrai S, Valcz G, Szigeti KA, Barták BK, Nagy ZB, Dank M, Liposits Z, Igaz P, Tulassay Z, Molnár B. Leiszter K, et al. Among authors: dank m. Orv Hetil. 2020 Apr;161(14):532-543. doi: 10.1556/650.2020.31674. Orv Hetil. 2020. PMID: 32223415 Hungarian.
[Diffuse intestinal malignant lymphoma].
Kónya L, Mikó P, Dank M, Vallent K, Fehér J. Kónya L, et al. Among authors: dank m. Orv Hetil. 1989 Jan 29;130(5):235-8. Orv Hetil. 1989. PMID: 2915897 Hungarian.
[Pharmaceutical therapy of breast cancer].
Láng I, Kahán Z, Pintér T, Dank M, Boér K, Pajkos G, Faluhelyi Z, Pikó B, Eckhardt S, Horváth Z. Láng I, et al. Among authors: dank m. Magy Onkol. 2010 Sep;54(3):237-54. doi: 10.1556/MOnkol.54.2010.3.5. Magy Onkol. 2010. PMID: 20870601 Free article. Hungarian. No abstract available.
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.
Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jaenicke F, Pluzanska A, Dank M, Becquart D, Bapsy PP, Salminen E, Snyder R, Chaudri-Ross H, Lang R, Wyld P, Bhatnagar A. Mouridsen H, et al. Among authors: dank m. J Clin Oncol. 2003 Jun 1;21(11):2101-9. doi: 10.1200/JCO.2003.04.194. J Clin Oncol. 2003. PMID: 12775735 Clinical Trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel.
Steger GG, Abrahámová J, Bacanu F, Brincat S, Brize A, Cesas A, Cufer T, Dank M, Duchnowska R, Eniu A, Jassem J, Kahán Z, Matos E, Padrik P, Plāte S, Pokker H, Purkalne G, Timcheva C, Tzekova V, Vyzula R, Zielinski CC. Steger GG, et al. Among authors: dank m. Wien Klin Wochenschr. 2010 Jun;122(11-12):368-79. doi: 10.1007/s00508-010-1373-6. Epub 2010 Jun 15. Wien Klin Wochenschr. 2010. PMID: 20549373
Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations.
Brown D, Smeets D, Székely B, Larsimont D, Szász AM, Adnet PY, Rothé F, Rouas G, Nagy ZI, Faragó Z, Tőkés AM, Dank M, Szentmártoni G, Udvarhelyi N, Zoppoli G, Pusztai L, Piccart M, Kulka J, Lambrechts D, Sotiriou C, Desmedt C. Brown D, et al. Among authors: dank m. Nat Commun. 2017 Jun 6;8:15759. doi: 10.1038/ncomms15759. Nat Commun. 2017. PMID: 28585536 Free PMC article.
156 results